Royce & Associates’s Diversified Healthcare Trust DHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-455,126
Closed -$1.41M 974
2021
Q4
$1.41M Sell
455,126
-1,403,094
-76% -$4.53M 0.01% 767
2021
Q3
$6.3M Sell
1,858,220
-411,908
-18% -$1.55M 0.05% 535
2021
Q2
$9.49M Sell
2,270,128
-96,510
-4% -$398K 0.07% 442
2021
Q1
$11.3M Buy
2,366,638
+1,725,912
+269% +$7.94M 0.08% 410
2020
Q4
$2.64M Buy
+640,726
New +$2.52M 0.02% 678

Other funds holding DHC

Royce & Associates's DHC Position: Q1 2022 in Review

Royce & Associates sold out of Diversified Healthcare Trust (DHC) in Q1 2022, closing a stake of 455,126 shares — an estimated $1.41M sold.

Royce & Associates first reported a position in DHC in Q4 2020 and held it in 5 quarters. The position peaked at $11.3M in Q1 2021. 239 funds tracked by Wall St. Rank hold DHC as of Q1 2022.

  • Royce & Associates reported no remaining Diversified Healthcare Trust position as of Q1 2022 after selling out during the quarter.
  • Royce & Associates sold 455,126 Diversified Healthcare Trust shares in Q1 2022, an estimated $1.41M.
  • Royce & Associates first reported a position in Diversified Healthcare Trust in Q4 2020 and held it in 5 quarters.
  • Royce & Associates's Diversified Healthcare Trust position peaked at $11.3M in Q1 2021.
  • 239 funds tracked by Wall St. Rank held Diversified Healthcare Trust as of Q1 2022.

Based on Royce & Associates's 13F filing for Q1 2022, filed 5 May 2022.